A research study to explore the impact of GP support via text messages to patients with asthma and/or chronic obstructive pulmonary disease

Not Applicable

Completed

• Conditions: Asthma, chronic obstructive pulmonary disease (COPD); Respiratory; Asthma, Other chronic obstructive pulmonary disease

• Registration Number: ISRCTN10376144
• Lead Sponsor: Accurx

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-08-09
• Study Completion: 2023-11-01
• Last Update Posted: 4 December 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 4000

Inclusion Criteria

1. Willing and able to provide informed consent and comply with the study instructions
2. Male and females age 18 years or older
3. Confirmed diagnosis of asthma and/or COPD as recorded in the patient’s GP medical record
4. Currently prescribed a preventer inhaler
5. Access to a mobile phone
6. Ability to check text messages on phone
7. Ability to read

Exclusion Criteria

1. Inability to understand the study procedures
2. Inability or reluctance to provide responses to the study questionnaires
3. Inability to receive and respond to text messages

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Medication adherence measured using the MARS-5 Questionnaire from baseline (week 1) to midpoint (week 13) and endpoint (week 26)

Secondary Outcome Measures

Name	Time	Method
<br> 1. Symptom control measured using the Asthma Control Test from baseline (week 1) to midpoint (week 13) and endpoint (week 26). (for asthma patients)<br> 2. Symptom control measured using the COPD Assessment Test from baseline (week 1) to midpoint (week 13) and endpoint (week 26) (for COPD patients and patients with both asthma and COPD)<br> 3. Days between consecutive preventer inhaler prescription requests measured using medical record data from baseline (week 1) to midpoint (week 13) and endpoint (week 26)<br> 4. Differences in the number of emergency admissions between the intervention and control groups measured using bespoke survey questions over the 26-week trial period<br> 5. Differences in the utilisation of NHS resources between the intervention and control groups measured using bespoke survey questions over the 26-week trial period<br>